BACKGROUND: Blacks have a higher prevalence of left ventricular hypertrophy than whites. Several population-based studies have reported an inverse association between adiponectin and left ventricular mass (LVM); however, the relationship between adiponectin levels and LVM has yet to be defined in blacks. The Jackson Heart Study cohort provides an opportunity to test the hypothesis that the inverse association between adiponectin and LVM may be modified by risk factors common among blacks. METHODS AND RESULTS: The study population included 2649 black Jackson Heart Study participants (mean age 51±12 years, 63% women, 51% obese, 54% with hypertension, and 16% with diabetes). Multiple linear and spline regression was used to assess the association, with adjustment for demographic, clinical, and behavioral covariates. Among all the participants, there was a statistically significant but modest inverse association between adiponectin and LVM index. Hypertension and insulin resistance emerged as statistically significant effect modifiers of this relationship. The inverse association present among the normotensive participants was explained by obesity measures such as the body mass index. Among participants with both hypertension and insulin resistance, there was a significant direct association between adiponectin and the LVM index after multivariable adjustment (β=1.55, P=0.04, per 1-SD increment in the adiponectin log value). CONCLUSIONS: The association between serum adiponectin and LVM among blacks in the Jackson Heart Study cohort was dependent on hypertension and insulin resistance status. Normotensive blacks exhibited an inverse adiponectin-LVM association, whereas participants with hypertension and insulin resistance had a direct association.
BACKGROUND: Blacks have a higher prevalence of left ventricular hypertrophy than whites. Several population-based studies have reported an inverse association between adiponectin and left ventricular mass (LVM); however, the relationship between adiponectin levels and LVM has yet to be defined in blacks. The Jackson Heart Study cohort provides an opportunity to test the hypothesis that the inverse association between adiponectin and LVM may be modified by risk factors common among blacks. METHODS AND RESULTS: The study population included 2649 black Jackson Heart Study participants (mean age 51±12 years, 63% women, 51% obese, 54% with hypertension, and 16% with diabetes). Multiple linear and spline regression was used to assess the association, with adjustment for demographic, clinical, and behavioral covariates. Among all the participants, there was a statistically significant but modest inverse association between adiponectin and LVM index. Hypertension and insulin resistance emerged as statistically significant effect modifiers of this relationship. The inverse association present among the normotensive participants was explained by obesity measures such as the body mass index. Among participants with both hypertension and insulin resistance, there was a significant direct association between adiponectin and the LVM index after multivariable adjustment (β=1.55, P=0.04, per 1-SD increment in the adiponectin log value). CONCLUSIONS: The association between serum adiponectin and LVM among blacks in the Jackson Heart Study cohort was dependent on hypertension and insulin resistance status. Normotensive blacks exhibited an inverse adiponectin-LVM association, whereas participants with hypertension and insulin resistance had a direct association.
Authors: David D McManus; Asya Lyass; Erik Ingelsson; Joseph M Massaro; James B Meigs; Jayashri Aragam; Emelia J Benjamin; Ramachandran S Vasan Journal: Obesity (Silver Spring) Date: 2011-02-24 Impact factor: 5.002
Authors: Martin K Rutter; Helen Parise; Emelia J Benjamin; Daniel Levy; Martin G Larson; James B Meigs; Richard W Nesto; Peter W F Wilson; Ramachandran S Vasan Journal: Circulation Date: 2003-01-28 Impact factor: 29.690
Authors: Jorge R Kizer; Donna K Arnett; Jonathan N Bella; Mary Paranicas; D C Rao; Michael A Province; Albert Oberman; Dalane W Kitzman; Paul N Hopkins; Jennifer E Liu; Richard B Devereux Journal: Hypertension Date: 2004-05-03 Impact factor: 10.190
Authors: Richard Lorber; Samuel S Gidding; Martha L Daviglus; Laura A Colangelo; Kiang Liu; Julius M Gardin Journal: J Am Coll Cardiol Date: 2003-03-19 Impact factor: 24.094
Authors: Joshua J Joseph; Justin B Echouffo-Tcheugui; Rita R Kalyani; Hsin-Chieh Yeh; Alain G Bertoni; Valery S Effoe; Ramon Casanova; Mario Sims; Adolfo Correa; Wen-Chih Wu; Gary S Wand; Sherita H Golden Journal: J Clin Endocrinol Metab Date: 2016-02-23 Impact factor: 5.958
Authors: Joshua J Joseph; Justin B Echouffo-Tcheugui; Sameera A Talegawkar; Valery S Effoe; Victoria Okhomina; Mercedes R Carnethon; Willa A Hsueh; Sherita H Golden Journal: Am J Prev Med Date: 2017-08-14 Impact factor: 5.043
Authors: Aferdita Spahillari; Sameera Talegawkar; Adolfo Correa; J Jeffrey Carr; James G Terry; João Lima; Jane E Freedman; Saumya Das; Robb Kociol; Sarah de Ferranti; Donya Mohebali; Stanford Mwasongwe; Katherine L Tucker; Venkatesh L Murthy; Ravi V Shah Journal: Circ Heart Fail Date: 2017-02 Impact factor: 8.790
Authors: Jorge R Kizer; David Benkeser; Alice M Arnold; Kenneth J Mukamal; Joachim H Ix; Susan J Zieman; David S Siscovick; Russell P Tracy; Christos S Mantzoros; Christopher R Defilippi; Anne B Newman; Luc Djousse Journal: Circulation Date: 2012-11-16 Impact factor: 29.690
Authors: Maria G Karas; David Benkeser; Alice M Arnold; Traci M Bartz; Luc Djousse; Kenneth J Mukamal; Joachim H Ix; Susan J Zieman; David S Siscovick; Russell P Tracy; Christos S Mantzoros; John S Gottdiener; Christopher R deFilippi; Jorge R Kizer Journal: Am J Cardiol Date: 2013-10-03 Impact factor: 2.778